stockrowDyne Therapeutics, Inc. (DYN) vs Tarsus Pharmaceuticals, Inc. (TARS)
- Dyne Therapeutics, Inc. DYN 18.19 +4.78%
- Tarsus Pharmaceuticals, Inc. TARS 67.49 −0.04%
Dyne Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.3B and $3.2B). Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −102.9%) and the lower return on invested capital (−1,956.3% vs 0.00%). Across the 14 metrics below, Dyne Therapeutics, Inc. leads on 9 and Tarsus Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | DYN | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 93.21% | 65.16% |
| Operating margin | 0.00% | (102.04%) | 0.00% |
| Net margin | 0.00% | (102.93%) | 0.00% |
| Free cash flow margin | 0.00% | 4.76% | 0.00% |
| Return on equity | (81.57%) | (319.84%) | (50.12%) |
| Return on assets | (60.29%) | (135.04%) | (45.60%) |
| Return on invested capital | (1,956.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack